Search results for: 'complex therapies'

29 Sep 2021  |  Global  |  Market Research

Global Industrial Computed Tomography (CT) System Growth Opportunities

Growing Structural Complexity Of Components, Tighter Tolerances, Evolving CT Software Solutions With AI/ML Capabilities, and Growing Additive Manufacturing (AM) Integration in Production Flow Will Drive Next Phase of Growth in Industrial CT Systems

Infographics

×

Key Issues Addressed

Industrial Computed Tomography (CT) systems are equipment used for dimensional measurement and defect inspection for external and internal aspects of manufactured parts, assemblies, and sub-assemblies. A key factor driving the need for industrial CT systems is the growing complexity in design and manufacturing of components that utilize new process...

17 Aug 2018  |  Global  |  Market Research

Global Manufacturing Execution Systems (MES) for Discrete Industry, Forecast to 2022

IIoT-enabled MES Solutions Will Help Overcome the Challenges of Legacy System, Uncertain Demand, and Complex Supply Chains

Infographics

×

Key Issues Addressed

Manufacturing execution systems are the integrated software applications that provide companies with the means to plan and schedule, track, direct, and implement their operations. The MES market is growing with the adoption of cloud computing and data analytics in distinct industry applications around the world. The market is likely to grow with th...

13 May 2021  |  Global  |  Market Research

Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market

Increased Focus on Patient Centricity and Diversity in Clinical Trials Provide Growth Opportunities for CROs and Technology Vendors

Infographics

×

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives in the contract research organization (CRO) market, covering the markets maturity, key participants, competitive landscape, and recent mergers and acquisitions. The study highlights key growth drivers and restraints, identifies initiatives by major global CROs, a...

20 Nov 2017  |  North America  |  Market Research

Global Biologics Market—Companies-to-Action

Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

Infographics

×

This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

Biologics, particularly peptide and protein therapies, are a rapidly growing therapeutic area because they can target complex biological pathways with high efficacy. These therapies are becoming important in oncology, metabolic disease, and autoimmune conditions supported by the growing global disease burden and growth in areas such as GLP-1s and m...

The rapid digital transformation, the expanding distributed environment, and the rising demand for high-performance applications and enhanced user experiences indicate the importance of converging both networking and security as businesses scale. Many organizations realize that they cannot leave security as an afterthought when transforming their n...

The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...

16 Jan 2025  |  Global  |  Technology Research

Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029

The emergence of novel pathogens and the reemergence of old pathogens are driving transformational growth by pushing therapeutic advancement.

Infographics

×

Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an analysis of clinical trials for 3 treatment modaliti...

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...